Ischemic heart disease (IHD) is the most common cardiovascular disease and is the main cause of death and disability worldwide. Myocardial ischemia/reperfusion (MI/R) injury has been linked to IHD-induced cardiomyocytes apoptosis and tissue damage. Recently, it has been reported that carnosic acid (CA) may function as a potent antioxidant in liver ischemia/reperfusion (I/R). However, whether it regulates I/R in the heart remains unclear. Here, we elucidated the emerging role of CA in MI/R under diabetic myocardial conditions. Diabetes mellitus (DM) was induced in mice by consumption of a high-fat diet for 16 weeks. To create the I/R in mice, the left anterior descending coronary artery was occluded for 30 min, and then occlusion was released to reperfuse the heart for 3 or 24 h. In diabetic myocardial ischemia/reperfusion (DMI/R) mice, pre-treatment with CA suppressed the overgeneration of reactive oxygen species (ROS) and production of cytokine. Importantly, the activation of autophagy was significantly increased by CA treatment, as assessed by p62 degradation and LC3-II/LC3-I conversion, as well as by phosphorylation of AMPKα, Akt, and mTOR. Interestingly, all of the protective effects of CA were impeded by the treatment with chloroquine, which is an autophagy inhibitor. These studies suggest that CA prevents DMI/R injury via regulation of autophagy. In conclusion, our findings indicate that CA has potential as a novel therapeutic to prevent DMI/R injury.
Impact statement
We have provided, for the first time, evidence that carnosic acid (CA) attenuates ischemia–reperfusion injury of diabetic myocardium, i.e. diabetic myocardial ischemia/reperfusion (DMI/R) injury, via enhancement of autophagy. A greater understanding of the target molecule in CA-enhanced autophagy is necessary for the development of potential chemotherapy for DMI/R injury.
BaldusSHeitzerTEiserichJPLauDMollnauHOrtakMPetriSGoldmannBDuchsteinHJBergerJHelmchenUFreemanBAMeinertzTMunzelT.Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion. Free Radical Biol Med2004;
37:902–11
2.
HyderAAPaichadzeNToroyanTPedenMM.Monitoring the decade of action for global road safety 2011-2020: an update. Glob Public Health2017;
12:1492–505
3.
RathmannWGianiG.Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care2004;
27:2568–9
4.
ThomTHaaseNRosamondWHowardVJRumsfeldJManolioTZhengZJFlegalKO'DonnellCKittnerSLloyd-JonesDGoffDCJr.HongYAdamsRFridayGFurieKGorelickPKisselaBMarlerJMeigsJRogerVSidneySSorliePSteinbergerJWasserthiel-SmollerSWilsonMWolfP.Heart disease and stroke statistics – 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation2006;
113:e85–151
5.
IrisJMVillasis-KeeverMA.Angiographic findings and outcome in diabetic patients with myocardial infarction – the GUSTO-I experience. J Am Coll Cardiol1998;
31:1699–701
6.
YuQGaoFMaXL.Insulin says NO to cardiovascular disease. Cardiovasc Res2011;
89:516–24
7.
GilbertRE.Endothelial loss and repair in the vascular complications of diabetes: pathogenetic mechanisms and therapeutic implications. Circ J2013;
77:849–56
8.
EverettBMBrooksMMVlachosHEChaitmanBRFryeRLBhattDL.Troponin and cardiac events in stable ischemic heart disease and diabetes. N Engl J Med2015;
373:610–20
9.
YellonDMHausenloyDJ.Myocardial reperfusion injury. N Engl J Med2007;
357:1121–35
10.
KobayashiSXuXChenKLiangQ.Suppression of autophagy is protective in high glucose-induced cardiomyocyte injury. Autophagy2012;
8:577–92
AragnoMMastrocolaRAlloattiGVercellinattoIBardiniPGeunaSCatalanoMGDanniOBoccuzziG.Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats. Endocrinology2008;
149:380–8
13.
SuHJiLXingWZhangWZhouHQianXWangXGaoFSunXZhangH.Acute hyperglycaemia enhances oxidative stress and aggravates myocardial ischaemia/reperfusion injury: role of thioredoxin-interacting protein. J Cell Mol Med2013;
17:181–91
14.
GhattasMHAbo-ElmattyDM.Association of polymorphic markers of the catalase and superoxide dismutase genes with type 2 diabetes mellitus. DNA Cell Biol2012;
31:1598–603
15.
AndersonEJKypsonAPRodriguezEAndersonCALehrEJNeuferPD.Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart. J Am Coll Cardiol2009;
54:1891–8
16.
BraunwaldE.Biomarkers in heart failure. N Engl J Med2008;
358:2148–59
17.
SteinerMPrielIGiatJLevyJSharoniYDanilenkoM.Carnosic acid inhibits proliferation and augments differentiation of human leukemic cells induced by 1,25-dihydroxyvitamin D3 and retinoic acid. Nutr Cancer2001;
41:135–44
18.
KimHSLeeJYLimSHParkKSunJMKoYHBaekCHSonYIJeongHSAhnYCLeeMYHongMAhnMJ.Association between PD-L1 and HPV status and the prognostic value of PD-L1 in oropharyngeal squamous cell carcinoma. Cancer Res Treat2016;
48:527–36
19.
WangYTaoLYuanYLauWBLiRLopezBLChristopherTATianRMaXL.Cardioprotective effect of adiponectin is partially mediated by its AMPK-independent antinitrative action. Am J Physiol Endocrinol Metab2009;
297:E384–91
20.
ZweierJLTalukderMA.The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res2006;
70:181–90
21.
MaxwellSRLipGY.Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol1997;
58:95–117
22.
PetrosilloGRuggieroFMDi VenosaNParadiesG.Decreased complex III activity in mitochondria isolated from rat heart subjected to ischemia and reperfusion: role of reactive oxygen species and cardiolipin. FASEB J2003;
17:714–6
23.
HristovaMRocha-FerreiraEFontanaXTheiLBuckleRChristouMHompoonsupSGostelowNRaivichGPeeblesD.Inhibition of signal transducer and activator of transcription 3 (STAT3) reduces neonatal hypoxic-ischaemic brain damage. J Neurochem2016;
136:981–94
24.
AustinGEChanWCZhaoWRacineM.Myeloperoxidase gene expression in normal granulopoiesis and acute leukemias. Leuk Lymphoma1994;
15:209–26
25.
KalaszJPasztorETFagyasMBaloghATothACsatoVEdesIPappZBorbelyA.Myeloperoxidase impairs the contractile function in isolated human cardiomyocytes. Free Radic Biol Med2015;
84:116–27
26.
JungCHRoSHCaoJOttoNMKimDH.mTOR regulation of autophagy. FEBS Lett2010;
584:1287–95
27.
HanZCaoJSongDTianLChenKWangYGaoLYinZFanYWangC.Autophagy is involved in the cardioprotection effect of remote limb ischemic postconditioning on myocardial ischemia/reperfusion injury in normal mice, but not diabetic mice. PLoS One2014;
9:e86838
28.
MorrisGWalkerAJBerkMMaesMPuriBK.Cell death pathways: a novel therapeutic approach for neuroscientists. Mol Neurobiol2018;
55:5767–86
29.
HuynhKKiriazisHDuXJLoveJEJandeleit-DahmKAForbesJMMcMullenJRRitchieRH.Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes. Diabetologia2012;
55:1544–53
30.
KokaSDasASalloumFNKukrejaRC.Phosphodiesterase-5 inhibitor tadalafil attenuates oxidative stress and protects against myocardial ischemia/reperfusion injury in type 2 diabetic mice. Free Radic Biol Med2013;
60:80–8
31.
LesnefskyEJChenQTandlerBHoppelCL.Mitochondrial dysfunction and myocardial ischemia-reperfusion: implications for novel therapies. Annu Rev Pharmacol Toxicol2017;
57:535–65
32.
MartinCZhangY.The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol2005;
6:838–49
33.
VilleneuveLMReddyMALantingLLWangMMengLNatarajanR.Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc Natl Acad Sci U S A2008;
105:9047–52
34.
ChenXEl GazzarMYozaBKMcCallCE.The NF-kappaB factor RelB and histone H3 lysine methyltransferase G9a directly interact to generate epigenetic silencing in endotoxin tolerance. J Biol Chem2009;
284:27857–65
35.
ParzychKRKlionskyDJ.An overview of autophagy: morphology, mechanism, and regulation. Antioxidants Redox Signal2014;
20:460–73
36.
SaxtonRASabatiniDM.mTOR signaling in growth, metabolism, and disease. Cell2017;
168:960–76
37.
KabeyaYMizushimaNYamamotoAOshitani-OkamotoSOhsumiYYoshimoriT.LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J Cell Sci2004;
117:2805–12
38.
LiuWJYeLHuangWFGuoLJXuZGWuHLYangCLiuHF.p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation. Cell Mol Biol Lett2016;
21:29
39.
LammingDWYeLSabatiniDMBaurJA.Rapalogs and mTOR inhibitors as anti-aging therapeutics. J Clin Invest2013;
123:980–9
40.
LiangXHJacksonSSeamanMBrownKKempkesBHibshooshHLevineB.Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature1999;
402:672–6
41.
XieZLauKEbyBLozanoPHeCPenningtonBLiHRathiSDongYTianRKemDZouMH.Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice. Diabetes2011;
60:1770–8
NaveBTOuwensMWithersDJAlessiDRShepherdPR.Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem J1999;
344:427–31
44.
PetersonRTBealPACombMJSchreiberSL.FKBP12-rapamycin-associated protein (FRAP) autophosphorylates at serine 2481 under translationally repressive conditions. J Biol Chem2000;
275:7416–23
45.
LaplanteMSabatiniDM.mTOR signaling in growth control and disease. Cell2012;
149:274–93
46.
MaSWangYChenYCaoF.The role of the autophagy in myocardial ischemia/reperfusion injury. Biochim Biophys Acta2015;
1852:271–6
47.
AoyagiTKusakariYXiaoCYInouyeBTTakahashiMScherrer-CrosbieMRosenzweigAHaraKMatsuiT.Cardiac mTOR protects the heart against ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol2012;
303:H75–85
48.
GurusamyNLekliIMukherjeeSRayDAhsanMKGherghiceanuMPopescuLMDasDK.Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway. Cardiovasc Res2010;
86:103–12
49.
VolkersMKonstandinMHDoroudgarSTokoHQuijadaPDinSJoyoAOrnelasLSamseKThueraufDJGudeNGlembotskiCCSussmanMA.Mechanistic target of rapamycin complex 2 protects the heart from ischemic damage. Circulation2013;
128:2132–44
50.
HwangSJKimW.Mitochondrial dynamics in the heart as a novel therapeutic target for cardioprotection. Chonnam Med J2013;
49:101–7
51.
EltzschigHKEckleT.Ischemia and reperfusion – from mechanism to translation. Nat Med2011;
17:1391–401
